Abstract
Alprazolam, when added under double-blind conditions to a stable neuroleptic regimen in two patients with schizophrenia, resulted in clinically apparent improvement in positive and negative schizophrenic symptoms. Both patients showed significant worsening of symptoms following reduction or discontinuation of alprazolam.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Alprazolam
-
Anti-Anxiety Agents / therapeutic use*
-
Antipsychotic Agents / therapeutic use
-
Benzodiazepines / therapeutic use*
-
Double-Blind Method
-
Drug Therapy, Combination
-
Fluphenazine / therapeutic use*
-
Humans
-
Male
-
Psychiatric Status Rating Scales
-
Schizophrenia / drug therapy*
-
Schizophrenic Psychology
Substances
-
Anti-Anxiety Agents
-
Antipsychotic Agents
-
Benzodiazepines
-
Fluphenazine
-
Alprazolam